Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: A 4-year study;Evolução da resistência aos antimicrobianos entre isolados clínicos de enterococos em um hospital terciário brasileiro: Um estudo de 4 anos

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 44, Issue 2, 2011, Pages 177-181

  Conceição, Natália ^a   da Cunha Hueb Barata de Oliveira, Cristina ^a   da Silva, Paulo Roberto ^a   Ávila, Bárbara Godoi Melo ^a   de Oliveira, Adriana Gonçalves ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Antimicrobial resistance profile; Enterococci; Enterococcus faecium; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; NORFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE; ENTEROCOCCUS PSEUDOAVIUM; GENE EXPRESSION; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCREENING TEST; TREND STUDY; VANA GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BRAZIL; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GENOTYPE; HUMANS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 79957842154     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822011005000009     Document Type: Article

References (34)

1. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3:46-65.
2. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 2004; 50:56-69.
3. Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC. Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008). Braz J Infect Dis 2009; 13:90-98.
4. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342:710-721.
5. Courvalin P. Genetics of glycopeptide resistance in gram-positive pathogens. Int J Med Microbiol 2005; 294:479-486.
6. Dalla-Costa LM, Souza DC, Martins LTF, Zanella RC, Brandileone MC, Bokermann S, et al. Vancomycin-resistant Enterococcus faecium: first case in Brazil. Braz J Infect Dis 1998; 2:160-163.
7. Zanella RC, Valdetaro F, Lovgren M, Tyrrel GJ, Bokermann S, Almeida SC, et al. First confirmed case of a vancomycin-resistant Enterococcus faecium with vanA phenotype from Brazil: isolation from a meningitis case in São Paulo. Microb Drug Resist 1999; 5:159-162.
8. Bender EA, Freitas ALP, Reiter KC, Lutz L, Barth AL. Identification, antimicrobial resistance and genotypic characterization of Enterococcus spp. isolated in Porto Alegre, Brazil. Braz J Microbiol 2009; 40:693-700.
9. Caiaffa Filho HH, Almeida GD, Oliveira GA, Sarahyba L, Mamizuka EM, Burattini MN. Molecular characterization of van genes found in vancomycin resistant Enterococcus spp. isolated from Hospital das Clínicas, FMUSP, São Paulo, Brazil. Braz J Infect Dis 2003; 7:173-174.
10. Cereda RF, Sader HS, Jones RN, Sejas L, Machado AM, Zanatta YP, Rego STMS, Medeiros EAS. Enterococcus faecalis resistant to vancomycin and teicoplanin (VanA phenotype) isolated from a bone marrow transplanted patient in Brazil. Braz J Infect Dis 2001; 5:40-46.
11. Cordeiro JC, Silbert S, Reis AO, Sader HS. Inter-hospital dissemination of glycopeptides resistant Enterococcus faecalis in Brazil. Clin Microbiol Infect 2004; 3:260-262.
12. Ribas RM, Darini ALC, Moreira TA, Freitas C, Gontijo Filho PP. Vancomycinresistant vanA phenotype Enterococcus faecalis: first case in Minas Gerais state and epidemiological considerations. Braz J Infec Dis 2007; 11:439-440.
13. Zanella RC, Brandileone MCC, Bokermann S, Almeida SCG, Valdetaro F, Vitório F, et al. Phenotypic and genotypic characterization of vanA Enterococcus isolated during the first nosocomial outbreak in Brazil. Microb Drug Resist 2003; 9:283-291.
14. Teixeira LM, Carvalho MGS, Facklam RR. Enterococcus. In: Murray BE, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of Clinical Microbiology. Washington (DC): American Society for Microbiology; 2007. p. 430-442.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Ninth tenth Informational Supplement. Wayne: CLSI document M100-S19; 2009.
16. Woodford N, Morrison D, Johnson AP, Briant V, George RC, Cookson B. Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31:653-658.
17. Dutka-malen S, Evers S, Courvalin P. Detection of glicopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33:24-27.
18. Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J Hosp Infect 2010; 75:225-227.
19. Furtado GHC, Martins ST, Coutinho AN, Soares GMM, Wey SB, Medeiros EAS. Incidence of vancomycin-resistance Enterococcus at a university hospital in Brazil. Rev Saude Publica 2005; 39:41-46.
20. Sader HS, Moet GJ, Jones RN. Antimicrobial resistance among gram-positive bacteria isolated in Latin American hospitals. J Chemother 2009; 21:611-620.
21. Deshpande LM, Fritsche TR, Moet GJ, Biendenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2007; 58:163-170.
22. Leavis HL, Bonten MJM, Willems RJL. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. Curr Opin Microbiol 2006; 9:454-460.
23. Oteo J, Cuevas O, Navarro C, Aracil B, Campos J. Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001-06, Spain): increasing ampicillin resistance in Enterococcus faecium. J Antimicrob Chemother 2007; 59:1044-1045.
24. Shepard BD, Gilmore MS. Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance. Microbes Infect 2002; 4:215-224.
25. Treitman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol 2005; 43:462-463.
26. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008; 13:1-11.
27. Camargo ILBC, Gilmore MS, Darini ALC. Multilocus sequence typing and analysis of putative virulence factors in vancomycin-resistant and vancomycinsensitive Enterococcus faecium isolates from Brazil. Clin Microbiol Infect 2006; 12:1123-1130.
28. Titze-de-Almeida R, Van Belkum A, Felipe MSS, Zanella RC, Top J, Willems RJL. Multilocus sequence typing of hospital associated Enterococcus faecium from Brazil reveals their unique evolutionary history. Microb Drug Res 2006; 12:121-125.
29. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of Enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32:S133-145.
30. Lautenbach E, Gould CV, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, et al. Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates. Intern J Antimicrob Agents 2004; 23:200-203.
31. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC. SENTRY antimicrobial surveillance program report: Latin American and Brazilian result for 1997 through 2001. Braz J Infect Dis 2004; 8:25-79.
32. d'Azevedo PA, Dias CAG, Lemos SK, Bittencourt JAF, Teixeira LM. Antimicrobial susceptibility among Enterococcus isolates from the city of Porto Alegre, RS, Brazil. Braz J Infect Dis 2004; 35:199-204.
33. Sader HS, Gales AC, Pfaller MA, Mendes RE, Zocolli C, Barth A, et al. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 2001; 5:200-214.
34. Sader HS, Jones RN. Antimicrobial susceptibility of gram-positive bacteria isolated from US medical centers: results of the daptomycin surveillance program (2007-2008). Diagn Microbiol Infect Dis 2009; 65:158-162.